7.2 mg semaglutide clinical trial Once-weekly 7·2 in adults with obesity (STEP UP): a randomised, controlled, phase 3b European Commission Approves 7.2 mg – The Ozempic Pill Has Arrived.

Take our free GLP-1 Health Assessment to get a personalized recommendation from one of our licensed providers

M.ChoiY

Free radicals are oxygen molecules that have an odd number of electrons, which means that they can interact with other molecules when theyre not supposed to, causing a condition called oxidation

26,27 Weight gain is likely to have implications for patients physical and mental well-being, and the combination of T2D and obesity has been shown to negatively impact QOL

So many healthcare professionals suggest continuing semaglutide for a long-term weight management plan

However, despite its effectiveness for many, some individuals may find they are not losing weight as expected